New cancer clinical trial: Feasibility of FMISO in Brain Tumors

Published on: August 28, 2018 at 12:00PM
Condition:   Malignant Brain Neoplasm
Interventions:   Drug: ¹⁸F-Fluoromisonidazole;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2oiCSPJ